跳至主要内容
临床试验/IRCT20200304046698N1
IRCT20200304046698N1已完成3 期

Evaluation and comparison of the effects and complications of escitalopram and citalopram on depression in patients with chronic renal failure undergoing hemodialysis

Yazd University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with major depressive disorder with minimum depression score of 13 with Hamilton Test and psychiatrist approval
  • Patients with renal failure who have been undergoing hemodialysis treatment for at least 3 months

排除标准

  • Systemic medical disease (heart disease, diabetes, epilepsy, hypertension, thyroid) that interferes with medication use or follow-up.
  • Liver failure, Hepatitis B and C, HIV / AIDS
  • Existence of psychiatric disorder other than depression
  • Patient being treated with SSRIs (if previously treated after 3 months treatment)
  • Pregnancy or lactation
  • Addiction to all kinds of drugs and psychotropics
  • The occurrence of any unbearable side effects in the patient

研究者

发起方
Yazd University of Medical Sciences

相似试验

Effects of escitalopram and Citalopram on Depression... | 临床试验